Patents by Inventor Matthew Cove

Matthew Cove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10322221
    Abstract: A method of reducing the concentration of carbon dioxide in blood plasma includes removing blood from a patient and treating or processing at least blood plasma of the blood by flowing the blood plasma on one side of at least one semi-permeable membrane and flowing a dialysate on the other side of the at least one semi-permeable membrane. The dialysate has a concentration of bicarbonate less than the concentration of bicarbonate in the blood plasma before treating the blood plasma and has a composition such that the blood plasma strong ion difference that results from treating the blood plasma in conjunction with an achieved reduction in blood plasma CO2 concentration results in a blood plasma pH that does not change by more than +/?0.5 during treatment.
    Type: Grant
    Filed: January 18, 2014
    Date of Patent: June 18, 2019
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: John Alston Kellum, Jr., Matthew Cove, William J. Federspiel
  • Publication number: 20150335807
    Abstract: A method of reducing the concentration of carbon dioxide in blood plasma includes removing blood from a patient and treating or processing at least blood plasma of the blood by flowing the blood plasma on one side of at least one semi-permeable membrane and flowing a dialysate on the other side of the at least one semi-permeable membrane. The dialysate has a concentration of bicarbonate less than the concentration of bicarbonate in the blood plasma before treating the blood plasma and has a composition such that the blood plasma strong ion difference that results from treating the blood plasma in conjunction with an achieved reduction in blood plasma CO2 concentration results in a blood plasma pH that does not change by more than +/?0.5 during treatment.
    Type: Application
    Filed: January 18, 2014
    Publication date: November 26, 2015
    Inventors: John Alston Kellum, JR., Matthew Cove, William J. Federspiel